|
|
|
News 2010:
| August 26, 2010 |
|
BioTime to Launch Seven New Embryonic Progenitor Cell Lines on September 1, 2010
|
| August 19, 2010 |
|
BioTime Raises $9.2 Million in Warrant Discount Offer, August 16, 2010
|
| August 16, 2010 |
|
BioTime Announces Second Quarter 2010 Financial Results and Recent Corporate Developments57% Increase in Total Revenue for the Quarter 99% Increase in Total Revenues Year to Date over Last Year, August 16, 2010
|
| July 21, 2010 |
|
BioTime Announces Addition of New Stem Cell Lines to Its Product Portfolio
|
| July 19, 2010 |
|
BioTime, Inc. Provides Financial Information about Its Acquisition of ES Cell International Pte Ltd.
|
| July 9, 2010 |
|
BioTime CEO Dr. Michael West to Present at the Agora Financial Investment Symposium 2010
|
| July 6, 2010 |
|
BioTime Announces Passing of Board Director Dr. Robert N. Butler
|
| June 18, 2010 |
|
BioTime Commences Warrant Discount Offer
|
| June 14, 2010 |
|
BioTime Announces Results of Vote at Annual Shareholders Meeting
|
| June 13, 2010 |
|
BioTime Set to Join Russell 3000 Index
|
| June 10, 2010 |
|
BioTime Forms New Subsidiary, OrthoCyte Corporation, to Develop Treatments for Orthopedic Conditions Using Stem Cell Technology
Arnold I. Caplan Ph.D., Founder of Osiris Therapeutics, Inc. Appointed Chief Scientific Officer
|
| June 8, 2010 |
|
BioTime CEO Dr. Michael West to Present at the Inaugural Jefferies Global Life Sciences Conference
|
| May 27, 2010 |
|
BioTime Adds Five New Stem Cell Lines to Its Product Portfolio
|
| May 21, 2010 |
|
BioTime CEO Dr. Michael West to Present at GTCbio 6th Annual Stem Cell Research & Therapeutics Conference
|
| May 10, 2010 |
|
BioTime Announces Receipt of $8 Million from Early Exercise of Warrants
|
| May 5, 2010 |
|
BioTime Announces First Quarter 2010 Financial Results and Recent Corporate Developments,159% Increase in Total Revenue for the Quarter
|
| May 3, 2010 |
|
BioTime, Inc. Announces Completion of ES Cell International Pte Ltd Acquisition
|
| April 29, 2010 |
|
BioTime, Inc. Provides Additional Information on Acquisition of Promissory Notes in Connection with Planned Acquisition of ES Cell International Pte Ltd.
|
| April 29, 2010 |
|
BioTime, Inc. Announces Agreement to Acquire ES Cell International
|
| March 16, 2010 |
|
BioTime, Inc. Reports Peer-Reviewed Scientific Publication On The Reversal Of The Developmental Aging Of Normal Human Cells
|
| March 10, 2010 |
|
BioTime Announces Fourth Quarter and Fiscal Year-End 2009 Financial Results and Recent Corporate Developments...163% Increase in Total Revenue for the Quarter...28% Increase in Total 2009 Revenue
|
| February 5, 2010 |
|
BioTime Reports Results from Independent HextendŽ Study
|
January 7, 2010
|
|
BioTime Subsidiary OncoCyte Corporation Receives Second $2,000,000 Equity Tranche; BioTime Plans Additional $2,250,000 Investment
|
January 5, 2010
|
|
BioTime Commences Shipment of Stem Cell Research Products to Millipore |
| |
|
|
| News 2009 |
| News 2008-2007 |
| |
|
|
|
|
|
|